ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01389622
Recruitment Status : Unknown
Verified March 2014 by Queen's University.
Recruitment status was:  Recruiting
First Posted : July 8, 2011
Last Update Posted : November 18, 2014
Sponsor:
Information provided by (Responsible Party):
Queen's University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Condition or disease Intervention/treatment Phase
Smoking Cessation Other: acupuncture Phase 2

Detailed Description:
Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs with varying degrees of success in different settings. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Effect of Self-administered Auricular Acupressure on Smoking Cessation—a Pilot Study
Study Start Date : July 2011
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : January 2016

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Arm 1: NADA points and digital pressure
Arm 1: NADA points and digital pressure with urge.
 Other: acupuncture
National Acupuncture Detoxification Association (NADA) points + digital pressure
Experimental: Arm 2: random points + digital pressure with urge
Arm 2 (20 participants): random points + digital pressure with urge
 Other: acupuncture
random points + digital pressure
No Intervention: Arm 3 (20 participants): NO acupressure, only advice + support


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Spot 7-day cessation rate [ Time Frame: Weekly during the intervention period (weeks 1-6) ]
    Efficacy of intervention for smoking cessation


Secondary Outcome Measures :
  1. Continuous Cessation Rate (CAR) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]
    Efficacy of intervention for smoking cessation

  2. End-expiratory carbon monoxide levels (CO) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]
    Efficacy of intervention for smoking cessation

  3. Adverse effects in terms of self-reported discomfort levels from auricular acupressure [ Time Frame: Weekly during the intervention period (weeks 1-6) ]
    Nature and incidence of adverse events due to intervention

  4. Stress level according to the Stress Check List (SCL) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]
    Nature and incidence of adverse events due to intervention

  5. Nicotine withdrawal symptoms according to Minnesota Nicotine Withdrawal Scale (MNWS) [ Time Frame: Weekly during the intervention period (weeks 1-6) and week 13 and week 26 ]
    Nature and incidence of adverse events due to intervention


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Participants are included in the study if they satisfy the following criteria:

    • Male or female.
    • Between 18 and 75 years of age inclusive.
    • Able to provide informed consent to study.
    • History of tobacco cigarette smoking for at least 6 months.
    • Confirmed intention of smoking cessation with no more than 2 previous failed attempts in the last 3 year.

Exclusion Criteria:

  • Existing pharmacotherapy for smoking cessation.
  • History of major psychiatric disorder or chronic pain syndromes.
  • More than 2 failed attempts of smoking cessation in the previous 3 years.
  • History of other substance abuse.
  • History of atopy, or suspected/known allergy to plaster.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01389622


Contacts
Contact: Lawrence Leung, MD 613-533-9303 lawrence.leung@dfm.queensu.ca
Contact: Jyoti Kotecha, MPA 613-533-6000 ext 73970 jyoti.kotecha@cspc.queensu.ca

Locations
Canada, Ontario
Queen's Family Health Team Recruiting
Kingston, Ontario, Canada, K7L 5E9
Contact: Lawrence Leung, MD    613-533-9300      
Contact: Jyoti Kotecha, MPA    613-533-6000 ext 73970    jyoti.kotecha@dfm.queensu.ca   
Sponsors and Collaborators
Queen's University
Investigators
Principal Investigator: Lawrence Leung, MD Queen's University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Queen's University
ClinicalTrials.gov Identifier: NCT01389622     History of Changes
Other Study ID Numbers: SMC01
First Posted: July 8, 2011    Key Record Dates
Last Update Posted: November 18, 2014
Last Verified: March 2014

Keywords provided by Queen's University:
Acupuncture
smoking cessation